CH339624A - Process for the preparation of a drug compound - Google Patents
Process for the preparation of a drug compoundInfo
- Publication number
- CH339624A CH339624A CH339624DA CH339624A CH 339624 A CH339624 A CH 339624A CH 339624D A CH339624D A CH 339624DA CH 339624 A CH339624 A CH 339624A
- Authority
- CH
- Switzerland
- Prior art keywords
- preparation
- drug compound
- parts
- acid
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/86—Hydrazides; Thio or imino analogues thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
<Desc/Clms Page number 1>
Verfahren zur Herstellung einer als Arzneimittel dienenden Verbindung Gegenstand des vorliegenden Patentes ist ein Verfahren zur Herstellung einer als Arzneimittel dienenden Verbindung, dadurch gekennzeichnet, dass man das Isonicotinsäurehydrazon des 3,4-Dimethoxy- benzaldehydes (3,4-Dimethoxy-l-benzyliden-isonico- tinsäurehydrazon) und p-Amino-salicylsäure in einem Lösungsmittel aufeinander einwirken lässt.
Die neue Verbindung soll als Pharmazeutikum für die Behandlung der Tuberkulose Verwendung finden.
Beispiel 1 285 Teile Isonicotinsäurehydrazon des 3,4-Di- methoxy-benzaldehydes werden in 2000 Teilen 0,5n Salzsäure gelöst und mit einer Lösung von 175 Teilen p-amino-salicylsaurem Na in 2000 Teilen Wasser versetzt. Es entsteht ein eigelbfarbener Niederschlag. Die neue Verbindung schmilzt bei 68 unter Zersetzung.
Beispiel 2 285 Teile Isonicotinsäurehydrazon des 3,4-Di- methoxy-benzaldehydes werden zusammen mit 156 Teilen p-Aminosalicylsäure in alkalischer, wässriger Lösung gelöst. Durch Ansäuern der Lösung mit einer Mineralsäure fällt die eigelb gefärbte Verbindung aus. Smp. 68 (unter Zersetzung).
<Desc / Clms Page number 1>
Process for the preparation of a compound serving as a medicament The subject of the present patent is a process for the preparation of a compound serving as a medicament, characterized in that the isonicotinic acid hydrazone of 3,4-dimethoxy-benzaldehyde (3,4-dimethoxy-1-benzylidene-isonico - tinsäurehydrazone) and p-amino-salicylic acid can act on each other in a solvent.
The new compound is said to be used as a pharmaceutical for the treatment of tuberculosis.
Example 1 285 parts of 3,4-dimethoxybenzaldehyde isonicotinic acid hydrazone are dissolved in 2000 parts of 0.5N hydrochloric acid, and a solution of 175 parts of p-aminosalicylic acid Na in 2000 parts of water is added. An egg-yellow-colored precipitate forms. The new compound melts at 68 with decomposition.
Example 2 285 parts of 3,4-dimethoxybenzaldehyde isonicotinic acid hydrazone are dissolved in alkaline, aqueous solution together with 156 parts of p-aminosalicylic acid. When the solution is acidified with a mineral acid, the egg-yellow colored compound precipitates. M.p. 68 (with decomposition).
Claims (1)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH339624T | 1956-01-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
CH339624A true CH339624A (en) | 1959-07-15 |
Family
ID=4505075
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH339624D CH339624A (en) | 1956-01-28 | 1956-01-28 | Process for the preparation of a drug compound |
Country Status (1)
Country | Link |
---|---|
CH (1) | CH339624A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007131813A1 (en) * | 2006-05-17 | 2007-11-22 | Basf Se | Condensation products, method for their production and use thereof in medicaments, as disinfectants or as a tannin |
-
1956
- 1956-01-28 CH CH339624D patent/CH339624A/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007131813A1 (en) * | 2006-05-17 | 2007-11-22 | Basf Se | Condensation products, method for their production and use thereof in medicaments, as disinfectants or as a tannin |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CH339624A (en) | Process for the preparation of a drug compound | |
DE952089C (en) | Process for the production of therapeutically valuable, water-soluble rhodan compounds | |
DE919351C (en) | Process for the preparation of new derivatives of isonicotinic acid amide | |
AT226217B (en) | Process for the preparation of the new 5-chloro-4-nitro-2-aminophenol | |
DE929550C (en) | Process for the preparation of 2-aminopyrimidine or its capsules | |
CH293018A (en) | Process for the preparation of a thiosemicarbazone of a heterocyclic aldehyde. | |
CH293020A (en) | Process for the preparation of a thiosemicarbazone of a heterocyclic aldehyde. | |
CH235948A (en) | Process for the preparation of p-amino-benzenesulfonyl-amino-pyridine-Bz-N-methylensulfosaurem piperazine. | |
AT154021B (en) | Process for the preparation of formaldehyde alkali sulfoxylates of arsenobenzene compounds | |
DE588650C (en) | Process for the preparation of oxydiphenyl ether carboxylic acids | |
DE356103C (en) | Process for the separation of sodium bisulphate in solid form from solutions | |
AT210413B (en) | Process for the preparation of a new complex compound of 5-nitrofurfural | |
AT160687B (en) | Process for the preparation of aminobenzenesulfonic acid amide compounds. | |
DE940830C (en) | Process for the preparation of penicillin salts | |
CH293021A (en) | Process for the preparation of a thiosemicarbazone of a heterocyclic aldehyde. | |
CH233731A (en) | Process for the preparation of an aromatic carboxamide. | |
CH192500A (en) | Process for the preparation of 2-ethoxypyridyl-5-azo-3'.5'-diaminopyridine. | |
CH233739A (en) | Process for the preparation of an aromatic carboxamide. | |
CH316628A (en) | Process for the preparation of a hydrazone of a heterocyclic aldehyde | |
CH299273A (en) | Process for the production of a thiosemicarbazone. | |
CH253640A (en) | Process for the preparation of 2- (3 ', 5'-dibromo-salicoylamino) -thiazole. | |
CH221823A (en) | Process for the preparation of a new benzimidazole derivative. | |
CH318825A (en) | Process for the preparation of a naphthalene series disulfonic acid | |
CH172629A (en) | Process for obtaining a therapeutically valuable compound of the heterocyclic series. | |
CH407133A (en) | Process for the preparation of a new oxadiazoline derivative |